Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 16/20 | 0.59 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.46 |
| ▸ | MASP2 | O00187 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3157747 | 1.00 | F2 (0.59) | F2KLKB1MASP2PRSS1 | |
| SCHEMBL3157648 | 0.89 | F2 (0.57) | F2KLKB1MASP2PRSS1 | |
| SCHEMBL3154741 | 0.86 | F2 (0.58) | F2KLKB1MASP2 | |
| SCHEMBL3149590 | 0.86 | F2 (0.58) | F2KLKB1MASP2 | |
| SCHEMBL3157965 | 0.85 | F2 (0.60) | F2MASP2PRSS1 | |
| SCHEMBL3140046 | 0.84 | F2 (0.49) | F2MASP2 | |
| SCHEMBL3139987 | 0.80 | F2 (0.56) | F2KLKB1MASP2 | |
| SCHEMBL4306897 | 0.80 | F2 (0.51) | F2KLKB1MASP2 | |
| SCHEMBL4308027 | 0.80 | F2 (0.51) | F2KLKB1MASP2 | |
| SCHEMBL3144724 | 0.79 | MASP2 (0.46) | MASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100076015-A1 | Aminopyridine Derivatives | VANTIA LIMITED (GB) | 2010-03-25 | — | — | US | disclosed |
| WO-2009133348-A1 | AMINOPYRIDINE DERIVATIVES | VANTIA LIMITED (GB) | 2009-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076015-A1 | Aminopyridine Derivatives | CHRM1, ARG1, ARG2 | F2 1046/4885KLKB1 3491/4885MASP2 3039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.